4//SEC Filing
Camut Christopher C 4
Accession 0001104659-09-003894
CIK 0001326190other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:30 PM ET
Size
14.3 KB
Accession
0001104659-09-003894
Insider Transaction Report
Form 4
Camut Christopher C
VP, Chief Financial Officer
Transactions
- Award
Common Stock, $0.0001 par value per share
2009-01-21+25,308→ 49,308 total - Award
Stock Option (right to buy)
2009-01-21+25,308→ 240,308 totalExercise: $2.46Exp: 2019-01-21→ Common Stock (25,308 underlying)
Footnotes (3)
- [F1]This is a restricted stock award, which vests over a 3 year period with 33 1/3% vesting on the first anniversary of the grant date or 1/21/2010, 33 1/3% vesting on the second anniversary of the grant date or 1/21/2011, and the balance vesting on the third anniversary of the grant date or 1/21/2012.
- [F2]The option vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
- [F3]On January 21, 2009, the date such stock options were granted and restricted stock was awarded, the closing price of the Issuer's common stock was $2.46 per share.
Documents
Issuer
PHARMATHENE, INC
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001409861
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 4:30 PM ET
- Size
- 14.3 KB